Loading clinical trials...
Loading clinical trials...
A Pilot Study of Camrelizumab With Chemotherapy in Adults With Medically Inoperable Early Stage Non-Small Cell Lung Cancer (NSCLC)
Conditions
Interventions
Biological: Camrelizumab
Pemetrexed
+1 more
Locations
1
China
Tianjin Medical University Cancer Institute and Hospital
Tianjin, China
Start Date
September 25, 2020
Primary Completion Date
June 30, 2025
Completion Date
December 31, 2025
Last Updated
November 13, 2020
Lead Sponsor
Tianjin Medical University Cancer Institute and Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions